Wellesley Hills Financial Goes Global: New London and New York Hubs Signal Aggressive Expansion into Transatlantic Fintech M&A
12.3.2026 13:00:00 CET | Business Wire | Press release
With the addition of industry veterans Barry Davis and Bill Shraga, WHF strengthens its cross-border capabilities and scales its specialized Merchant Portfolios platform to a national level.
Wellesley Hills Financial (“WHF”), a premier fintech and payments-focused investment bank spanning the lower to upper middle market, today announced a series of senior appointments and geographic expansions that further scale its global advisory platform and deepens its capabilities across the payments and fintech ecosystems.
The firm has appointed Barry Davis as Executive Advisor, based in London, added Managing Director Bill Shraga in New York, and expanded its payments consulting subsidiary, Merchant Portfolios (“MP”), with the addition of EVPs Lance McCord in North Carolina and Nolan Pittman in Arizona.
Strengthening Transatlantic Connectivity
Barry Davis joins WHF as the firm’s first London-based Executive Advisor, marking a significant milestone in WHF’s international expansion. His appointment establishes a dedicated presence in the U.K. and enhances the firm’s existing ability to advise European fintech and payments companies seeking U.S. capital, strategic partnerships, and cross-border transaction execution.
Mr. Davis brings decades of leadership experience across merchant acquiring, payments infrastructure, and financial technology, along with deep relationships throughout the U.K. and European markets.
“Fintech and payments innovation is increasingly global, and our clients require advisors who can operate seamlessly across borders,” said Adam T. Hark, Managing Member of WHF. “Barry’s leadership in London meaningfully expands our international reach and positions WHF as a stronger bridge between European innovators and investors, and U.S. capital and strategic buyers.”
Expanding Senior Coverage in Key U.S. Financial Markets
WHF has also strengthened its U.S. footprint with the addition of Managing Director Bill Shraga in New York, establishing a formal senior presence in one of the world’s most influential financial centers. This expansion enhances the firm’s access to institutional investors, strategic acquirers, and private equity sponsors while increasing coverage for clients across fintech, payments, embedded finance and financial services.
Together, the London and New York appointments reflect WHF’s strategy to build a globally connected advisory platform designed specifically for the evolving payments and fintech landscape.
Scaling Merchant Portfolios as a National Advisory Platform
WHF’s payments consulting subsidiary, Merchant Portfolios, continues to grow as demand accelerates for specialized advisory services tailored to merchant acquiring businesses.
MP has expanded into the Southeast and Southwest with the appointments of EVPs Lance McCord and Nolan Pittman. The firm has also added dedicated M&A advisory and fractional CFO capabilities, further strengthening its ability to support portfolio sales, enterprise transactions, financial planning, valuations, and operational strategy.
“Merchant Portfolios is evolving into a national platform purpose-built for merchant acquiring and payments companies navigating growth, consolidation, and increasing financial complexity,” said Anthony Malatesta, Managing Director. “By expanding geographically and adding senior M&A and financial leadership expertise, we are delivering more integrated and strategic support to owners and operators.”
Building the Next Phase of Growth
These strategic investments reflect WHF’s broader vision: building a globally connected, sector-specialized advisory platform that supports fintech and payments companies through every stage of growth, capital formation, and strategic transformation.
As cross-border activity, private equity participation, and consolidation continue to shape the payments and fintech landscape, WHF is positioning itself at the center of that evolution.
About Wellesley Hills Financial
Wellesley Hills Financial is an investment bank and advisory firm serving fintech, payments, and financial services companies. The firm provides mergers and acquisitions advisory, capital raising, valuations, and strategic guidance to growth-oriented businesses across the financial technology ecosystem.
About Merchant Portfolios
Merchant Portfolios, a subsidiary of Wellesley Hills Financial, provides specialized consulting and advisory services to merchant acquiring and payments companies, including portfolio and enterprise sales, financial planning and analysis, valuations, growth strategy, fractional CFO and transaction support.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260312105842/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Owkin Creates New Spin out Waiv, Formerly Owkin Dx, With $33M Financing12.3.2026 14:30:00 CET | Press release
Investment lead by OTB Ventures and Alpha Intelligence CapitalWaiv develops AI-powered precision testing to better identify and stratify patients in the clinic and in clinical trials, transforming patient careWaiv extends Owkin’s strategy of real-world validation for its AI Owkin, the AI company on a mission to solve the complexity of biology, today announced the spin out of Waiv, formerly known as Owkin Dx. The move follows significant investor interest and positions Waiv to bring AI-powered precision testing for better identification of patients in the clinic and in clinical trials, to transform patient care. This follows on from the successful launch of Bioptimus, an Owkin incubated company, in February 2024. Waiv translates AI innovation into real-world clinical impact, developing tests that predict biomarkers and patient outcomes, including RlapsRisk BC for prognostic risk profiling. With multiple tests already in use in clinical settings, its deployment platform Destra, and colla
RQM+ Launches SMART Solutions Life Cycle Partnership Model12.3.2026 14:30:00 CET | Press release
Helps MedTech Companies Navigate MDR, IVDR, and AI-Enabled Device Development RQM+, a leading MedTech CRO offering regulatory consulting, clinical trial, laboratory, and reimbursement services, today announced the launch of SMART Solutions, a life cycle partnership model designed to help medical device and diagnostics companies manage growing regulatory and development complexity. SMART Solutions introduces a strategy-led operating framework that unifies regulatory, quality, clinical, reimbursement, and laboratory expertise to support MedTech companies across the entire product life cycle to help reduce risk from early development through post-market. “MedTech companies are navigating unprecedented complexity as regulatory expectations evolve, product innovation accelerates, and post-market expectations are expanding,” said John Potthoff, Ph.D., chief executive officer of RQM+. “SMART Solutions moves beyond traditional consulting by providing an integrated life cycle partnership that h
Cryptio Raises $45m Series B as Digital Assets Move Into Regulated Financial Markets12.3.2026 14:06:00 CET | Press release
The system of record for tokenized finance – ERP infrastructure for institutions operating in digital assets Cryptio, a leader in financial data transformation and enterprise resource planning (ERP) applications for regulated digital assets, announced today a $45 million Series B funding round co-led by BlackFin Capital Partners and Sentinel Global, with participation from 1kx, Alven, BlueYard Capital and Ledger Cathay Capital. Banks, exchanges, asset managers, including Société Générale’s SG Forge, Circle, Gemini, and Securitize rely on Cryptio to ensure financial integrity across their digital assets businesses. Existing ERP systems fall short for digital assets Traditional ERP and accounting systems were not designed for blockchain-native assets, real-time reporting, or modern custody frameworks. As regulated financial institutions expand into stablecoins, tokenized securities and other on-chain instruments, these limitations create material operational and reporting challenges. Cry
HyperLight Introduces 145 GHz Reference Modulators to Enable 448Gbps per Lane Datacom and 260GBaud Telecom Development12.3.2026 14:03:00 CET | Press release
HyperLight Corporation, creator of the TFLN Chiplet™ platform, today announced the release of its 145 GHz Packaged Intensity Modulator (IM), expanding the company‘s high-speed modulator portfolio. The new device is designed for ultra-wide modulation bandwidth, high signal fidelity, and stable operation control, enabling 448 Gbps per lane intensity-modulated-direct-detection (IMDD), 260 GBaud coherent links, and broadband RF photonics systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260312319685/en/ Fig. 1: HyperLight’s 145 GHz intensity modulator for 448Gbps per lane IMDD and 260GBaud coherent applications, with operational electro-optical bandwidth >145GHz, stable bias control, 0.8 mm-connector; available in O-, C-, and L-bands. As symbol rates and analog bandwidth requirements continue to rise across data center interconnects, AI-driven photonics infrastructure, and laboratory test environments, system architects in
Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences12.3.2026 14:00:00 CET | Press release
Transaction deepens insights into Sec61 selectivity for targeted protein degradation, supporting accelerated development of Enodia’s novel small-molecule inhibitors Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degradation at the point of synthesis, and Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that Enodia has acquired Kezar’s assets from its Sec61-based discovery and development program. The acquisition enables Enodia to advance its understanding of Sec61 selectivity mechanisms, expanding biological and translational insights for faster progression toward key clinical milestones. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260312627573/en/ Under the terms of the purchase agreement between Enodia and Kezar, Kezar w
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom